Media Centre

Featured Media Release
 

02 May 2011 - GSK to disclose payments to healthcare professionals by June 2011

As part of an ongoing commitment to increase transparency, GlaxoSmithKline announced today the intention to publish, by June 2011, the total amount of fees paid to Australian healthcare professionals for speaking and consulting services during 2010.

 
 

Media Releases


Indigenous and refugee programs win immunisation boost

GSK’s 2014 Immunisation Grants have been awarded to programs that are helping improve access and awareness of vaccination services for Indigenous and refugee communities.

14/10/2014

 

Arzerra® (ofatumumab) registered in Australia for first-line use in chronic lymphocytic leukaemia (CLL)...

GlaxoSmithKline announced today that the Therapeutic Goods Administration (TGA) has registered Arzerra® (ofatumumab), a human monoclonal antibody, in combination with chlorambucil or bendamustine for the treatment of patients in Australia with...

03/10/2014

 

International collaboration to develop inhaled form of oxytocin to manage bleeding after childbirth

GSK, Monash University, McCall MacBain Foundation, Grand Challenges Canada and Planet Wheeler Foundation join forces to develop oxytocin dry powder inhaler

26/09/2014

 

Night time bathroom visits - a trigger for men to visit the doctor

New Australian campaign launched that focusses on enlarged prostates

11/09/2014

 

Kimbra launches campaign to urge effective asthma management

Asthma Awareness Week – Popular recording artist and asthma sufferer Kimbra is joining forces with asthma experts and peak respiratory health groups today to launch the Asthma: Take Control campaign. The national campaign is urging people affected...

02/09/2014

 

Medicines Research Unit to Close

GSK today announced it will be closing the Medicines Research Unit at the Prince of Wales Hospital in Sydney.

28/08/2014

 

GSK Open Innovation brings opportunities to Australian & NZ innovators

An innovation program that helps develop ground-breaking health sector ideas around the world is calling upon Australian and New Zeland innovators to submit their ideas to the GSK Open Innovation website.

07/08/2014

 

GSK Response to Publication of Paracetamol in Low Back Pain Study (PACE)

Panadol is approved by the TGA for the effective relief of backache.

24/07/2014

 

New medicine for lupus now available in Australia

GSK is pleased to announce that BENLYSTA® (belimumab) is now available in Australia for use as an add-on therapy in adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) with a high degree of disease activity despite...

23/07/2014

 

Incruse® Ellipta® (umeclidinium) approved in Australia for Chronic Obstructive Pulmonary Disease

GlaxoSmithKline has announced today that the Therapeutic Goods Administration (TGA) has approved Incruse® Ellipta® (umeclidinium), a maintenance treatment to relieve symptoms in Australian adult patients with chronic obstructive pulmonary disease...

15/07/2014

1 2 3 4 5 6 7 8 9 10 11 >